Your browser doesn't support javascript.
loading
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19.
Ajmera, Veeral; Thompson, Wesley K; Smith, Davey M; Malhotra, Atul; Mehta, Ravindra L; Tolia, Vaishal; Yin, Jeffrey; Sriram, Krishna; Insel, Paul A; Collier, Summer; Richards, Lisa; Loomba, Rohit.
Afiliação
  • Ajmera V; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, United States of America; NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Thompson WK; Division of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, United States of America.
  • Smith DM; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Malhotra A; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Mehta RL; Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Tolia V; Department of Emergency Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Yin J; Department of Pharmacy, University of California San Diego, La Jolla, California, United States of America.
  • Sriram K; Department of Pharmacology, University of California San Diego, La Jolla, California, United States of America.
  • Insel PA; Department of Pharmacology, University of California San Diego, La Jolla, California, United States of America; Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California, United States of America.
  • Collier S; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Richards L; NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Loomba R; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, United States of America; NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, United States of America. Electronic address: roloomba@uc
Contemp Clin Trials ; 103: 106330, 2021 04.
Article em En | MEDLINE | ID: mdl-33631357

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ramipril / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ramipril / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article